LGD-6972

DB14779InvestigationalSmall molecule

LGD-6972 is under investigation in clinical trial NCT01919684 (Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LGD-6972 in Healthy Subjects and Subjects With Type 2 Diabetes Mellitus).

Formula / weight: C₄₃H₄₆N₂O₅S · 702.91 g/mol (avg)
Code names: LGD-6972

Resolves to

Compound

UNII6IJ842I0Z2CAS1207989-09-0

Structure

InChIKeyHKJMCBYPVCGZFB-LDLOPFEMSA-NSMILESCC1=CC(C)=C(C(C)=C1)C1=CC=C(NC(=O)[C@H](CC2=CC=C(C=C2)C(=O)NCCS(O)(=O)=O)C2=CC=C(C=C2)C2=CC=C(C=C2)C(C)(C)C)C=C1

Targets

P47871GCGR

What you can answer from here — as of April 23, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with LGD-6972, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account